AKT/AMPK-mediated phosphorylation of TBC1D4 disrupts the interaction with insulin-regulated aminopeptidase

Samaneh Eickelschulte1, Sonja Hartwig1, Ben Leiser2

  • 1Medical Faculty, Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany; German Center for Diabetes Research (DZD), Partner Düsseldorf, München-Neuherberg, Germany.

Insights

Full-length TBC1D4, a Rab GTPase-activating protein (RabGAP), forms large oligomers. Insulin and contraction signaling regulate TBC1D4 by disrupting its interaction with GLUT4 vesicles, not by altering its enzymatic activity.

Area of Science:

  • Molecular Biology
  • Cellular Metabolism
  • Signal Transduction

Background:

  • TBC1D4 is a Rab GTPase-activating protein (RabGAP) crucial for insulin-stimulated glucose transporter type 4 (GLUT4) trafficking.
  • Previous studies on TBC1D4 function were limited by the use of truncated domains lacking key phosphorylation sites.

Purpose of the Study:

  • To investigate the function of full-length TBC1D4, including its oligomeric state, enzymatic activity, and phosphorylation sites.
  • To determine how phosphorylation by AKT and AMPK affects TBC1D4's interaction with GLUT4 vesicles and its RabGAP activity.

Main Methods:

  • Expression and purification of recombinant full-length TBC1D4 using a baculovirus system.
  • Size-exclusion chromatography, coimmunoprecipitation, and high-resolution mass spectrometry.
  • In vitro kinase assays with purified kinases and stable isotope-labeled ATP to determine phosphorylation sites and kinetics.

Main Results:

  • Full-length TBC1D4 forms large oligomers (~600 kDa) and exhibits higher specific GAP activity toward Rab10 compared to truncated domains.
  • 19 Ser/Thr phosphorylation sites were mapped, with specific sites preferentially phosphorylated by AKT or AMPK.
  • Phosphorylation by AKT or AMPK did not alter TBC1D4's intrinsic RabGAP activity but disrupted its interaction with IRAP in GLUT4 vesicles.

Conclusions:

  • Insulin and contraction signaling regulate TBC1D4 function primarily by modulating its recruitment to GLUT4 vesicles via disruption of the IRAP interaction.
  • Full-length TBC1D4's oligomeric state and specific phosphorylation sites are critical for its role in GLUT4 trafficking.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.4K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.9K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.2K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
14.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.0K